SCHEMBL7007684

SCHEMBL7007684

CCCCc1cccc(-c2ccc[c]c2C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 4/20 0.38
LPL P06858 2/20 0.35
LIPG Q9Y5X9 2/20 0.35
PSMB5 P28074 1/20 0.34
HSD11B1 P28845 1/20 0.34
GPR3 P46089 1/20 0.32
BCL2L2 Q92843 1/20 0.32
XIAP P98170 1/20 0.32
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7011521 0.85 HSD11B1 (0.43) HSD11B1
SCHEMBL28400225 0.76 HTR7 (0.53) HTR7LPLLIPGPSMB5HSD11B1
SCHEMBL3209199 0.76 ENPP1 (0.45)
SCHEMBL2430766 0.74 NT5E (0.41) HTR7
SCHEMBL1207131 0.74 RORC (0.43) HTR7
SCHEMBL5198909 0.73 PDK2 (0.40) HTR7
SCHEMBL4279210 0.73 HSD17B1 (0.41)
SCHEMBL199210 0.73 LPL (0.52) LPLLIPGPSMB5HSD11B1XIAP
SCHEMBL8074571 0.72 PTPN5 (0.34)
SCHEMBL11067601 0.72 LIPG (0.35) LIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1345942-A2 PYRAZINOQUINOXALINE DERIVATIVES AS SEROTONIN AGONISTS AND ANTAGONISTS Bristol-Myers Squibb Pharma Company (US) 2003-09-24 EP claimed
JP-2003502336-A 2003-01-21 JP claimed
WO-2002059127-A2 PYRAZINOQUINOXALINE DERIVATIVES AS SEROTONIN AGONISTS AND ANTAGONISTS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-08-01 WO claimed
EP-1192165-A2 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES Bristol-Myers Squibb Pharma Company (US) 2002-04-03 EP claimed
WO-2000077010-A2 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES DU PONT PHARMACEUTICALS COMPANY (US) 2000-12-21 WO claimed